Normal Aging Brain Normal aging is associated with a progressive decline in cognitive performance, including perception, attention, language and memory [1-3]. Age-related functional and biochemical changes in the brain include alterations in cerebral metabolism, cerebral blood flow and neurotransmitter function. With the advent of functional neuroimaging techniques, these biochemical changes can be measured in vivo throughout the life span of person. Because functional disturbances herald structural changes, imaging with positron emission tomography (PET) may yield abnormal results whereas the brain anatomy appears to be normal. Several positronlabeled tracers have been presented to discern the distribution and activity of age-related biochemical changes in the brain. Change of Cerebral Metabolism There is an inconsistency in 18-fluorodeoxyglucose (FDG)-PET findings for aging brain. A number of studies in normal aging subjects have shown significant decrease in whole brain glucose metabolism with advancing age, while others have noted no noticeable change. Although some decline in local glucose metabolism in the temporal, parietal, and frontal areas has been reported by some studies, others have revealed that the prefrontal cortex is the most important region affected by aging. The divergence in results may be due to different methodologies, screening criteria, range of subject ages, and especially sample size, which is one of the key factors for obtaining consistent statistical results. In addition, most early studies on age-related glucose metabolism used region of interest (ROI) analysis. However, recently voxel-based analysis such as Statistical Parametric Mapping (SPM) package, have been widely used to help detect the area missed in ROI analysis and avoid subjective variation. Several studies have now characterized the effect of aging on the distribution of glucose metabolism using FDG-PET. Kuhl et al. [4] reported the use of FDG-PET for determining patterns of local cerebral glucose utilization in 40 normal